- Drug shortages in the US are nearing record highs, impacting treatment availability for patients suffering from life-threatening diseases, particularly cancer.
- Ryan Dwars (pictured) couldn’t receive his final four doses of chemotherapy.
- Factors contributing to this shortage include disrupted supply chains, quality concerns, and manufacturing shutdowns.
- The scarcity of generic drugs (90% of US prescriptions) has created delays in treatment and is prompting Congress to act.
- There is debate over potential remedies including tax incentives for generic drug makers and increased transparency around drug quality.
